Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA
May 16 2023 - 8:00AM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global
medicinal cannabis company, announced today that the Company has
received the Brazilian GMP certification by ANVISA, the Brazilian
Health Regulatory Agency, to manufacture cannabis products for
Brazilian patients.
Similar to the strict standards of the EU-GMP
certification, ANVISA’s Brazilian-GMP certification ensures that
patients receive the highest quality of medicine by preventing
cases of product contamination, variations in compounds
concentrations, mix-ups, incorrect labeling, and more. The
certification is required for the manufacturing and
commercialization of cannabis products in Brazil. Clever Leaves’
Colombia facility being awarded Brazilian-GMP marks the company’s
fifth international official certification and further attests to
the high-quality and premium standard practices that Clever Leaves
upholds in its production. Clever Leaves is the first and only
medicinal cannabis company globally who has GMP certifications from
the EU, Colombia and Brazil.
“The awarding of Brazilian-GMP certification
signifies a major milestone for Clever Leaves by further
highlighting our commitment to producing high-quality and safe
cannabis products that are trusted internationally and meet the
highest regulatory standards. The Brazilian market in particular
has the potential to become the largest cannabis market in Latin
America and one of the largest globally. We look forward to further
developing our presence in Brazil through our partners, with whom
we are already distributing finished cannabis products to medical
patients in the country,” said Andres Fajardo, CEO of Clever
Leaves.
Brazil currently has a population of over 210
million and has a regulatory framework for the use of medical
cannabis products authorized under the RDC 327/2019. In addition to
making Clever Leaves one of the few cannabis companies outside of
Brazil to receive ANVISA’s GMP certification, this certification,
along with the EU-GMP, will allow Clever Leaves to expand
operations into new and existing markets throughout the 5
continents that recognize international GMP standards and enable
patient access to Clever Leaves' high-quality products.
About Clever Leaves Holdings
Inc.Clever Leaves is a global medicinal cannabis company.
Its operations in Colombia produce cannabinoid active
pharmaceutical ingredients (API) and finished products in flower
and extract form to a growing base of B2B customers around the
globe. Clever Leaves aims to disrupt the traditional cannabis
production industry by leveraging environmentally sustainable,
ESG-friendly, industrial-scale and low-cost production methods,
with the world’s most stringent pharmaceutical quality
certifications. For more information, please
visit https://cleverleaves.com/en/home/.
Press Contacts:Rich
DiGregorioKCSA Strategic
Communications+1-856-889-7351cleverleaves@kcsa.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From Apr 2024 to May 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From May 2023 to May 2024